Clinical Trial

Effect of Extracorporeal Shock Wave Therapy on Spasticity and Mobility in Stroke Patients

Study acronym: ESWT-STROKE
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 14, 2026 (before its estimated April 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study aims to evaluate the effectiveness of extracorporeal shock wave therapy (ESWT) in individuals with lower limb spasticity following stroke. Spasticity is a common complication after stroke and can negatively affect walking ability, mobility, and quality of life. Participants will be randomly assigned to one of two groups. Both groups will receive a standard physiotherapy and rehabilitation program. In addition, the intervention group will receive ESWT applied to the lower limb muscles, while the control group will receive a sham (placebo) ESWT application. The treatment program will be conducted three times per week for four weeks. Clinical assessments will be performed at baseline, after treatment, and during follow-up. The main outcomes of the study include muscle tone (spasticity), walking performance, motor function, and quality of life. The results of this study may help improve rehabilitation strategies and provide evidence for the use of ESWT in stroke patients.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-04-04.
Trial Details
NCT Number NCT07523243
Lead Sponsor Istanbul Medipol University Hospital
Conditions Stroke, Post-Stroke Spasticity, Lower Limb Spasticity
Enrollment 85 participants
Start Date 2026-04
Primary Completion 2026-04-30 (estimated)
Study Completion 2026-06-20 (estimated)
Updated on ClinicalTrials.gov 2026-04-14